March is national Blood Clot Awareness Month in the United States, and the president of one national distributor of medical devices is always glad for the chance to discuss the dangers of clots.
At least one high-profile celebrity death in 2016 was caused by a blood clot.
New penalties took effect last month for hospitals with higher than expected rates of readmissions among Medicare patients.
A new scientific study draws a correlation between blood clot deaths and watching television.
The use of pneumatic compression devices is associated with improved health and reduced cost of care in lymphedema patients, according to a recent study.
The market for compression therapy is forecast to grow rapidly over the next several years.
Since arriving on the market in 2011, Xarelto has been prescribed to millions of Americans for the prevention of stroke and embolism. But thousands of lawsuits against Bayer and Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson, allege Xarelto puts patients at significant risk of uncontrollable bleeding. Some also accuse the companies of misleading marketing practices.
A pair of studies published in 2012 show an increased risk of blood clots among lung cancer patients.
The bill would classify compression therapy equipment as "durable medical devices" and clarify that such treatment is "reasonable and necessary." Compression therapy is gradually becoming more widespread as a preventative treatment for lymphedema and deep vein thrombosis.
Health care providers and advocacy groups around the world marked the second annual World Thrombosis Day on October 13, 2015. The movement's mission is to increase global awareness of thrombosis and reduce death and disability cause by the disease.